✦ LIBER ✦

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer

✍ Scribed by Angeles Alvarez Secord; Andrew Berchuck; Robert V. Higgins; Lawrence R. Nycum; Matthew F. Kohler; Larry E. Puls; Robert W. Holloway; George S. Lewandowski; Fidel A. Valea; Laura J. Havrilesky

Book ID: 112066943
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 421 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26610

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-related quality of life outcomes

✍ Robin Pokrzywinski; Angeles Alvarez Secord; Laura J. Havrilesky; Larry E. Puls; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 384 KB

Topotecan and carboplatin in patients wi

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

✍ Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 324 KB

A phase II clinical trial of pegylated l

A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A Double-blind, Randomized Phase lib Stu

A Double-blind, Randomized Phase lib Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared to Placebo (PL) When Administered in Combination with Docetaxel And/or Letrozole in Patients with Metastatic Breast Cancer (MBC): FM-B07-01 Trial

✍ G. Mariani; O. Burdaeva; L. Roman; E. Staroslawska; D. Udovitsa; P. Driol; G. Go 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views